Clinical Trial Update: A Proof-of-Concept Trial to Study the Safety and Activity of Linvoseltamab in Adult Participants With Smoldering Multiple Myeloma at High Risk of Developing Multiple Myeloma [Phase 2]

View source ↗

Summary

A Phase 2 proof-of-concept trial is evaluating the safety and activity of linvoseltamab in adults with smoldering multiple myeloma at high risk of progression.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Smoldering Multiple Myeloma

Drugs mentioned

• Linvoseltamab

Snippet

Sponsor: Regeneron Pharmaceuticals | Conditions: Smoldering Multiple Myeloma (SMM) | Phase 2 | Status: ACTIVE_NOT_RECRUITING